Breaking News Instant updates and real-time market news.

RETA

Reata Pharmaceuticals

$105.22 /

-51.94 (-33.05%)

14:44
08/10/20
08/10
14:44
08/10/20
14:44

Reata Pharmaceuticals price target lowered to $225 from $280 at Stifel

Stifel analyst Annabel Samimy lowered the firm's price target on Reata Pharmaceuticals to $225 from $280 and keeps a Buy rating on the shares. The analyst argues that months of uncertainty awaiting NDA filing was on display, with both programs - Bardoxolone and Omaveloxolone - seeing delays to ultimate submission. For Bard, she thinks Reata pushing filing until full submission of the 2-year data would alleviate FDA's question of how to consider the data within the context of an accelerated approval. Given only one quarter impact on NDA filing, Samimy expects this likely to be the ultimate outcome. With regard to Omav, the analyst was surprised by FDA's request for additional data, given the already sizable trial for this Orphan condition and inherent enrollment difficulties. Still, Reata is planning a crossover study of PBO patients from Phase 3, though FDA's acceptance of this proposal is in question, she contends.

  • 10

    Aug

  • 14

    Nov

RETA Reata Pharmaceuticals
$105.22 /

-51.94 (-33.05%)

08/10/20 BTIG
Reata adds uncertainty with 'long-awaited' updates, says BTIG
08/10/20 Jefferies
Reata Pharmaceuticals overreaction creates buying opportunity, says Jefferies
07/10/20 Stifel
Reata transferred with Buy rating, removed from Select List at Stifel
06/16/20 BTIG
Reata Pharmaceuticals initiated with a Buy at BTIG

TODAY'S FREE FLY STORIES

Hot Stocks
QuantumScape CEO: We pride ourselves on our transparency » 18:41
04/16/21
04/16
18:41
04/16/21
18:41
QS

QuantumScape

$35.52 /

-0.355 (-0.99%)

In an interview on…

In an interview on CNBC's Mad Money, Jagdeep Singh said QuantumScape has always been transparent about its data and about work that still needs to be done. "We're confident that the numbers we have are groundbreaking," he added. Singh noted that QuantumScape's core people have been with company for ten years and are not simply looking to make fast money. "They're a long-term committed team on a mission," he said. When asked about Scorpion Capital's allegations, he claimed that some of their points are "absurd."

ShowHide Related Items >><<
QS QuantumScape
$35.52 /

-0.355 (-0.99%)

QS QuantumScape
$35.52 /

-0.355 (-0.99%)

03/08/21 Cowen
Cowen bullish on battery technology, starts QuantumScape at Outperform
03/08/21 Cowen
QuantumScape initiated with an Outperform at Cowen
03/04/21 Baird
QuantumScape initiated with a Neutral at Baird
02/11/21 Morgan Stanley
QuantumScape initiated with an Overweight at Morgan Stanley
  • 25
    Mar
QS QuantumScape
$35.52 /

-0.355 (-0.99%)

QS QuantumScape
$35.52 /

-0.355 (-0.99%)

QS QuantumScape
$35.52 /

-0.355 (-0.99%)

Hot Stocks
Metromile CEO: Customers join initially because they save money » 18:24
04/16/21
04/16
18:24
04/16/21
18:24
MILE

Metromile

$7.96 /

-0.385 (-4.62%)

In an interview on…

In an interview on CNBC's Mad Money, Dan Preston said Metromile's customers save 47% on average relative to fixed rate insurance. He added that the company's word of mouth advertising is very strong as clients tend to share their positive experiences with many others. Metromile's customer retention rate is comparably better than most insurers, Preston noted.

ShowHide Related Items >><<
MILE Metromile
$7.96 /

-0.385 (-4.62%)

MILE Metromile
$7.96 /

-0.385 (-4.62%)

04/06/21 Piper Sandler
Metromile initiated with an Overweight at Piper Sandler
MILE Metromile
$7.96 /

-0.385 (-4.62%)

MILE Metromile
$7.96 /

-0.385 (-4.62%)

MILE Metromile
$7.96 /

-0.385 (-4.62%)

Hot Stocks
BlackRock senior managing director Wiedman sells 1,725 common shares » 17:16
04/16/21
04/16
17:16
04/16/21
17:16
BLK

BlackRock

$810.65 /

-8.11 (-0.99%)

In a regulatory filing,…

In a regulatory filing, BlackRock senior managing director Mark Wiedman disclosed the sale of 1,725 common shares of the company on April 16 at a price of $812.5268 per share.

ShowHide Related Items >><<
BLK BlackRock
$810.65 /

-8.11 (-0.99%)

BLK BlackRock
$810.65 /

-8.11 (-0.99%)

04/16/21 Credit Suisse
BlackRock price target raised to $984 from $949 at Credit Suisse
04/16/21 Deutsche Bank
BlackRock price target raised to $912 from $847 at Deutsche Bank
04/16/21 Citi
BlackRock price target raised to $1,000 from $950 at Citi
04/16/21 Barclays
BlackRock price target raised to $925 from $850 at Barclays
BLK BlackRock
$810.65 /

-8.11 (-0.99%)

  • 13
    May
BLK BlackRock
$810.65 /

-8.11 (-0.99%)

BLK BlackRock
$810.65 /

-8.11 (-0.99%)

Syndicate
Sellas Life Sciences files $150M mixed securities shelf  17:11
04/16/21
04/16
17:11
04/16/21
17:11
SLS

Sellas Life Sciences

$7.50 /

-0.38 (-4.82%)

 
ShowHide Related Items >><<
SLS Sellas Life Sciences
$7.50 /

-0.38 (-4.82%)

SLS Sellas Life Sciences
$7.50 /

-0.38 (-4.82%)

02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
12/21/20 Alliance Global Partners
Alliance Global Partners keeps Buy on Sellas following data from trials
SLS Sellas Life Sciences
$7.50 /

-0.38 (-4.82%)

SLS Sellas Life Sciences
$7.50 /

-0.38 (-4.82%)

SLS Sellas Life Sciences
$7.50 /

-0.38 (-4.82%)

Hot Stocks
Citadel Advisors reports 5.8% passive stake in AST SpaceMobile » 17:07
04/16/21
04/16
17:07
04/16/21
17:07
ASTS

AST SpaceMobile

$7.84 /

-0.61 (-7.22%)

Citadel Advisors…

Citadel Advisors disclosed a 5.8% stake in AST SpaceMobile, which represents over 3.01M shares. The filing does not allow for activism.

ShowHide Related Items >><<
ASTS AST SpaceMobile
$7.84 /

-0.61 (-7.22%)

ASTS AST SpaceMobile
$7.84 /

-0.61 (-7.22%)

ASTS AST SpaceMobile
$7.84 /

-0.61 (-7.22%)

Hot Stocks
Afya acquires Cliquefarma for R$19M » 17:05
04/16/21
04/16
17:05
04/16/21
17:05
AFYA

Afya

$23.84 /

+0.84 (+3.65%)

Afya announced the…

Afya announced the acquisition of 100% of the total share capital of Cliquefarma, a healthtech company operating a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices in Brazil. Users of Cliquefarma can search for medications or healthcare products and compare prices from over 5,000 pharmacies in Brazil. The traffic generated is monetized through a cost-per-click model, where drugstores pay for each click on their ads. In 2020 Cliquefarma generated traffic of 20M visitors and R$43.2M in gross merchandise volume, the latter representing a 52.9% growth compared to 2019. The aggregate purchase price is R$19M of which 84.2% paid in cash and 15.8% is paid in Afya stocks as the date hereof. An earn-out of R$3M can be paid related to product development. This aggregate purchase price is equivalent to a 4.1x gross revenue multiple for 2021 expected gross revenue.

ShowHide Related Items >><<
AFYA Afya
$23.84 /

+0.84 (+3.65%)

AFYA Afya
$23.84 /

+0.84 (+3.65%)

04/15/21 UBS
UBS upgrades Afya to Buy on 'underappreciated resiliency'
04/15/21 UBS
Afya upgraded to Buy from Neutral at UBS
02/04/21 JPMorgan
Afya upgraded to Overweight from Neutral at JPMorgan
10/19/20 JPMorgan
Afya downgraded to Neutral from Overweight at JPMorgan
AFYA Afya
$23.84 /

+0.84 (+3.65%)

AFYA Afya
$23.84 /

+0.84 (+3.65%)

Hot Stocks
USW proposes continuation of in-person negotiations with Allegheny Technologies » 16:54
04/16/21
04/16
16:54
04/16/21
16:54
ATI

Allegheny Technologies

$22.06 /

-0.1 (-0.45%)

The United Steelworkers…

The United Steelworkers said that the union has proposed returning to negotiations in-person with ATI to resolve the outstanding issues that led about 1,300 workers at nine facilities to strike over unfair labor practices on March 30, 2021. USW International Vice President David McCall, who chairs the union's negotiations with ATI, said that he hopes the overwhelming solidarity shown by the USW membership gives management an opportunity to show workers respect they have earned. "Our progress has been hindered at every step by the company dragging its feet and violating labor law," McCall said. "Now is the time for ATI to commit to resolve the outstanding issues in good faith at the bargaining table."

ShowHide Related Items >><<
ATI Allegheny Technologies
$22.06 /

-0.1 (-0.45%)

ATI Allegheny Technologies
$22.06 /

-0.1 (-0.45%)

03/16/21 Barclays
Allegheny Technologies upgraded to Overweight from Equal Weight at Barclays
01/15/21
Fly Intel: Top five analyst initiations
01/15/21 Seaport Global
Allegheny Technologies initiated with a Buy at Seaport Global
12/07/20 KeyBanc
Allegheny Technologies price target raised to $25 from $15 at KeyBanc
ATI Allegheny Technologies
$22.06 /

-0.1 (-0.45%)

Conference/Events
MGM Resorts to host analyst and investor virtual meeting » 16:54
04/16/21
04/16
16:54
04/16/21
16:54
MGM

MGM Resorts

$40.27 /

+0.59 (+1.49%)

Virtual Analyst &…

Virtual Analyst & Investor Meeting to be held on April 21 at 11 am. Webcast Link

ShowHide Related Items >><<
MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
04/06/21 Credit Suisse
Reports, contacts point to sports betting momentum in NY, Credit Suisse says
04/05/21
Fly Intel: Top five analyst upgrades
04/05/21 Morgan Stanley
Morgan Stanley upgrades MGM Resorts to Overweight after Vegas visit
MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

Syndicate
Brookfield files to sell 11.2M Class A limited voting shares  16:52
04/16/21
04/16
16:52
04/16/21
16:52
BAM

Brookfield

$46.09 /

-0.175 (-0.38%)

 
ShowHide Related Items >><<
BAM Brookfield
$46.09 /

-0.175 (-0.38%)

BAM Brookfield
$46.09 /

-0.175 (-0.38%)

04/09/21 Deutsche Bank
Brookfield price target raised to $45 from $43 at Deutsche Bank
04/01/21 Evercore ISI
Brookfield Property downgraded to In Line from Outperform at Evercore ISI
03/31/21
Fly Intel: Top five analyst downgrades
03/31/21 Credit Suisse
Brookfield downgraded to Neutral from Outperform at Credit Suisse
BAM Brookfield
$46.09 /

-0.175 (-0.38%)

BAM Brookfield
$46.09 /

-0.175 (-0.38%)

BAM Brookfield
$46.09 /

-0.175 (-0.38%)

Syndicate
Second Sight files to sell 4.65M shares of common stock for holders » 16:52
04/16/21
04/16
16:52
04/16/21
16:52
EYES

Second Sight

$7.37 /

-0.76 (-9.35%)

The filing for holders…

The filing for holders was released earlier this morning.

ShowHide Related Items >><<
EYES Second Sight
$7.37 /

-0.76 (-9.35%)

  • 01
    May
EYES Second Sight
$7.37 /

-0.76 (-9.35%)

EYES Second Sight
$7.37 /

-0.76 (-9.35%)

EYES Second Sight
$7.37 /

-0.76 (-9.35%)

Syndicate
EyeGate files to sell 3.93M shares of common stock for holders  16:52
04/16/21
04/16
16:52
04/16/21
16:52
EYEG

EyeGate

$4.26 /

+0.06 (+1.43%)

 
ShowHide Related Items >><<
EYEG EyeGate
$4.26 /

+0.06 (+1.43%)

EYEG EyeGate
$4.26 /

+0.06 (+1.43%)

03/31/21 Alliance Global Partners
EyeGate price target lowered to $10.25 from $16.75 at Alliance Global
02/04/21 Alliance Global Partners
EyeGate price target raised to $16.75 from $15.50 at Alliance Global Partners
12/22/20 Alliance Global Partners
EyeGate price target raised to $15.50 from $9.50 at Alliance Global Partners
12/22/20 H.C. Wainwright
EyeGate price target raised to $14 from $10 at H.C. Wainwright
Hot Stocks
FDA revokes emergency use authorization for Eli Lilly's bamlanivimab » 16:46
04/16/21
04/16
16:46
04/16/21
16:46
LLY

Eli Lilly

$189.25 /

+3.28 (+1.76%)

The U.S. FDA revoked the…

The U.S. FDA revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients. Based on its ongoing analysis of emerging scientific data, specifically the sustained increase of SARS-CoV-2 viral variants that are resistant to bamlanivimab alone resulting in the increased risk for treatment failure, the FDA has determined that the known and potential benefits of bamlanivimab, when administered alone, no longer outweigh the known and potential risks for its authorized use. Therefore, the agency determined that the criteria for issuance of an authorization are no longer met and has revoked the EUA. Reference Link

ShowHide Related Items >><<
LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

Hot Stocks
Kforce CEO sells 50K shares of common stock » 16:45
04/16/21
04/16
16:45
04/16/21
16:45
KFRC

Kforce

$56.62 /

+1.22 (+2.20%)

In a regulatory filing,…

In a regulatory filing, Kforce disclosed that its CEO David Dunkel sold 50K shares of common stock on April 14th in a total transaction size of $2.8M, reducing his stake by about 6%.

ShowHide Related Items >><<
KFRC Kforce
$56.62 /

+1.22 (+2.20%)

KFRC Kforce
$56.62 /

+1.22 (+2.20%)

03/11/21 Truist
Kforce price target raised to $55 from $48 at Truist
01/20/21 Truist
Kforce price target raised to $48 from $37 at Truist
01/04/21 Sidoti
Kforce upgraded to Buy from Neutral at Sidoti
08/11/20 Truist
Kforce price target raised to $35 from $30 at Truist
KFRC Kforce
$56.62 /

+1.22 (+2.20%)

KFRC Kforce
$56.62 /

+1.22 (+2.20%)

Hot Stocks
Oak Street Health CMO sells 109.4K shares of common stock » 16:44
04/16/21
04/16
16:44
04/16/21
16:44
OSH

Oak Street Health

$58.67 /

+0.99 (+1.72%)

In a regulatory filing,…

In a regulatory filing, Oak Street Health disclosed that its Chief Medical Officer Griffin Myers sold 109.4K shares of common stock on April 15th in a total transaction size of $6.28M, reducing his stake by about 2%.

ShowHide Related Items >><<
OSH Oak Street Health
$58.67 /

+0.99 (+1.72%)

OSH Oak Street Health
$58.67 /

+0.99 (+1.72%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 Evercore ISI
Oak Street Health initiated with an Outperform at Evercore ISI
03/10/21 Piper Sandler
Oak Street Health accelerating revenue growth 'not baked in,' says Piper Sandler
02/24/21 Canaccord
Canaccord starts Oak Street Health at Buy with $67 price target
OSH Oak Street Health
$58.67 /

+0.99 (+1.72%)

  • 11
    Feb
  • 03
    Dec
  • 06
    Aug
OSH Oak Street Health
$58.67 /

+0.99 (+1.72%)

Hot Stocks
Icahn cuts Tenneco stake to 13.35% from 14.03% » 16:44
04/16/21
04/16
16:44
04/16/21
16:44
TEN

Tenneco

$10.81 /

+0.07 (+0.65%)

In a regulatory filing,…

In a regulatory filing, Carl Icahn disclosed a 13.35% stake in Tenneco, representing 10,946,841 shares. The move decreases Icahn's stake from 14.03%. The filing allows for activism.

ShowHide Related Items >><<
TEN Tenneco
$10.81 /

+0.07 (+0.65%)

TEN Tenneco
$10.81 /

+0.07 (+0.65%)

04/01/21 Jefferies
Tenneco initiated with a Buy at Jefferies
03/25/21 Wells Fargo
Tenneco initiated with an Overweight at Wells Fargo
02/25/21 Deutsche Bank
Tenneco price target raised to $15 from $13 at Deutsche Bank
01/20/21 Deutsche Bank
Tenneco price target raised to $13 from $11 at Deutsche Bank
TEN Tenneco
$10.81 /

+0.07 (+0.65%)

TEN Tenneco
$10.81 /

+0.07 (+0.65%)

TEN Tenneco
$10.81 /

+0.07 (+0.65%)

Hot Stocks
PPD CEO sells 100K shares of common stock » 16:43
04/16/21
04/16
16:43
04/16/21
16:43
PPD

PPD

$46.30 /

+0.49 (+1.07%)

In a regulatory filing,…

In a regulatory filing, PPD disclosed that its CEO David Simmons sold 100K shares of common stock on April 14th in a total transaction size of $4.2M, reducing his stake by about 7%.

ShowHide Related Items >><<
PPD PPD
$46.30 /

+0.49 (+1.07%)

PPD PPD
$46.30 /

+0.49 (+1.07%)

04/16/21 Deutsche Bank
PPD downgraded to Hold from Buy at Deutsche Bank
04/16/21 William Blair
PPD downgraded to Market Perform from Outperform at William Blair
04/16/21 Evercore ISI
Thermo Fisher price target raised to $540 from $525 at Evercore ISI
04/16/21 Evercore ISI
PPD downgraded to In Line from Outperform at Evercore ISI
PPD PPD
$46.30 /

+0.49 (+1.07%)

  • 17
    Sep
PPD PPD
$46.30 /

+0.49 (+1.07%)

PPD PPD
$46.30 /

+0.49 (+1.07%)

Conference/Events
HP Enterprise participates in a conference call with Wells Fargo » 16:38
04/16/21
04/16
16:38
04/16/21
16:38
HPE

HP Enterprise

$15.94 /

+0.08 (+0.50%)

Conference call with…

Conference call with President & CEO Neri will be held on April 21 at 1 pm hosted by Wells Fargo. Webcast Link

ShowHide Related Items >><<
HPE HP Enterprise
$15.94 /

+0.08 (+0.50%)

HPE HP Enterprise
$15.94 /

+0.08 (+0.50%)

04/08/21 Morgan Stanley
HP Enterprise price target raised to $17 from $15.50 at Morgan Stanley
03/26/21 JPMorgan
HP Enterprise price target raised to $18 from $17 at JPMorgan
03/10/21
Fly Intel: Top five analyst upgrades
03/10/21 Daiwa
HP Enterprise upgraded to Outperform from Neutral at Daiwa
HPE HP Enterprise
$15.94 /

+0.08 (+0.50%)

HPE HP Enterprise
$15.94 /

+0.08 (+0.50%)

HPE HP Enterprise
$15.94 /

+0.08 (+0.50%)

Syndicate
Immunic files to sell 581,199 shares of common stock for holders  16:34
04/16/21
04/16
16:34
04/16/21
16:34
IMUX

Immunic

$14.22 /

-1.24 (-8.02%)

 
ShowHide Related Items >><<
IMUX Immunic
$14.22 /

-1.24 (-8.02%)

IMUX Immunic
$14.22 /

-1.24 (-8.02%)

04/15/21 Piper Sandler
Piper Sandler 'very encouraged' by Immunic Phase 2 EMPhASIS cohort 2 data
04/15/21 Aegis
Immunic initiated with a Buy at Aegis
03/24/21
Fly Intel: Top five analyst initiations
03/24/21 JMP Securities
Immunic initiated with an Outperform at JMP Securities
IMUX Immunic
$14.22 /

-1.24 (-8.02%)

  • 05
    Aug
  • 10
    Jun
IMUX Immunic
$14.22 /

-1.24 (-8.02%)

Syndicate
Citi files $100M mixed securities shelf  16:34
04/16/21
04/16
16:34
04/16/21
16:34
C

Citi

$72.46 /

-0.07 (-0.10%)

 
ShowHide Related Items >><<
C Citi
$72.46 /

-0.07 (-0.10%)

C Citi
$72.46 /

-0.07 (-0.10%)

04/13/21 Morgan Stanley
Citi price target raised to $89 from $81 at Morgan Stanley
04/09/21 Jefferies
Citi price target raised to $85 from $75 at Jefferies
04/07/21 Barclays
Citi price target raised to $84 from $77 at Barclays
04/05/21 Cowen
Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
C Citi
$72.46 /

-0.07 (-0.10%)

C Citi
$72.46 /

-0.07 (-0.10%)

C Citi
$72.46 /

-0.07 (-0.10%)

C Citi
$72.46 /

-0.07 (-0.10%)

Options
Preliminary option volume of 39.4M today » 16:30
04/16/21
04/16
16:30
04/16/21
16:30

Preliminary option volume…

Preliminary option volume of 39.4M today is 14% above recent average. Calls led puts 24.74M to 14.71M.

On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:29
04/16/21
04/16
16:29
04/16/21
16:29
MS

Morgan Stanley

$78.58 /

-2.31 (-2.86%)

, BK

BNY Mellon

$46.05 /

-1.97 (-4.10%)

, CFG

Citizens Financial

$44.82 /

+0.15 (+0.34%)

, STT

State Street

$80.46 /

-6.07 (-7.01%)

, C

Citi

$72.46 /

-0.07 (-0.10%)

, ALXN

Alexion

$163.62 /

+6.19 (+3.93%)

, AZN

AstraZeneca

$50.74 /

-0.1 (-0.20%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

, BA

Boeing

$248.11 /

-3.09 (-1.23%)

, SQSP

Squarespace

/

+

, LSCC

Lattice Semiconductor

$57.90 /

+6.77 (+13.24%)

, PPG

PPG

$167.43 /

+13.57 (+8.82%)

, AA

Alcoa

$35.63 /

+2.765 (+8.41%)

, EDIT

Editas Medicine

$34.63 /

-6.28 (-15.35%)

, SPLK

Splunk

$134.31 /

-14.09 (-9.49%)

, MRNA

Moderna

$170.77 /

+10.95 (+6.85%)

, PFE

Pfizer

$38.57 /

+0.96 (+2.55%)

The major averages closed…

ShowHide Related Items >><<
STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

04/16/21 Wells Fargo
Wells Fargo 'expected more' from Morgan Stanley after disclosing Archegos loss
04/09/21 JMP Securities
Goldman Sachs price target raised to $400 from $338 at JMP Securities
04/07/21 Barclays
Morgan Stanley price target raised to $98 from $95 at Barclays
04/01/21 Deutsche Bank
Morgan Stanley price target raised to $79 from $68 at Deutsche Bank
BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

04/09/21 Deutsche Bank
BNY Mellon price target raised to $54 from $50 at Deutsche Bank
04/07/21 Barclays
BNY Mellon price target raised to $57 from $55 at Barclays
03/26/21 JPMorgan
JPMorgan sees BNY Mellon, Wells Fargo among banks with most buyback capacity
03/24/21
Fly Intel: Top five analyst upgrades
CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

04/09/21 Jefferies
Citizens Financial price target raised to $47 from $42 at Jefferies
04/07/21 Barclays
Citizens Financial price target raised to $54 from $49 at Barclays
04/01/21 Deutsche Bank
Citizens Financial price target raised to $50 from $44 at Deutsche Bank
03/30/21 Stephens
Citizens Financial price target raised to $54 from $45 at Stephens
STT State Street
$80.46 /

-6.07 (-7.01%)

04/09/21 Deutsche Bank
State Street price target raised to $100 from $97 at Deutsche Bank
04/07/21 Barclays
State Street price target raised to $104 from $99 at Barclays
04/01/21 Wells Fargo
State Street price target raised to $90 from $83 at Wells Fargo
04/01/21 Morgan Stanley
State Street price target raised to $103 from $102 at Morgan Stanley
C Citi
$72.46 /

-0.07 (-0.10%)

04/13/21 Morgan Stanley
Citi price target raised to $89 from $81 at Morgan Stanley
04/09/21 Jefferies
Citi price target raised to $85 from $75 at Jefferies
04/07/21 Barclays
Citi price target raised to $84 from $77 at Barclays
04/05/21 Cowen
Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
ALXN Alexion
$163.62 /

+6.19 (+3.93%)

03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
03/23/21 SVB Leerink
Alexion downgraded to Market Perform from Outperform at SVB Leerink
02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/12/21 Argus
AstraZeneca downgraded to Hold from Buy at Argus
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
BA Boeing
$248.11 /

-3.09 (-1.23%)

04/15/21 Credit Suisse
Boeing price target raised to $233 from $193 at Credit Suisse
04/14/21 JPMorgan
Boeing price target raised to $260 from $230 at JPMorgan
04/09/21 Baird
Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
03/29/21 Goldman Sachs
Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
SQSP Squarespace
/

+

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

02/17/21 Craig-Hallum
Lattice Semiconductor price target raised to $40 from $31 at Craig-Hallum
02/17/21 KeyBanc
Lattice Semiconductor price target raised to $57 from $50 at KeyBanc
02/17/21 Cowen
Lattice Semiconductor price target raised to $56 from $48 at Cowen
02/17/21 Susquehanna
Lattice Semiconductor price target raised to $56 from $52 at Susquehanna
PPG PPG
$167.43 /

+13.57 (+8.82%)

04/15/21 Citi
Citi opens '30-day negative catalyst watch' on Axalta, PPG
04/07/21 Wells Fargo
PPG price target raised to $173 from $165 at Wells Fargo
03/15/21 Credit Suisse
PPG assumed with a Neutral at Credit Suisse
01/26/21 BofA
PPG upgraded to Buy from Neutral at BofA
AA Alcoa
$35.63 /

+2.765 (+8.41%)

04/16/21 B. Riley
Alcoa price target raised to $36 from $20 at B. Riley
04/16/21 BMO Capital
Alcoa price target raised to $38 from $36 at BMO Capital
03/24/21 Morgan Stanley
Morgan Stanley upgrades Alcoa to Overweight on better prospects for aluminum
EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

04/16/21
Fly Intel: Top five analyst initiations
04/16/21 Goldman Sachs
Editas Medicine initiated with a Sell at Goldman Sachs
03/22/21 Credit Suisse
Editas Medicine initiated with an Outperform at Credit Suisse
03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
SPLK Splunk
$134.31 /

-14.09 (-9.49%)

04/16/21
Fly Intel: Top five analyst downgrades
04/16/21 KeyBanc
Splunk downgraded to Sector Weight from Overweight at KeyBanc
04/08/21 BofA
Splunk reinstated with a Buy at BofA
04/08/21 BofA
Splunk reinstated with a Buy at BofA
MRNA Moderna
$170.77 /

+10.95 (+6.85%)

04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

  • 21
    Jan
  • 24
    Jun
  • 19
    May
STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

Conference/Events
Amyris to host conference call » 16:24
04/16/21
04/16
16:24
04/16/21
16:24
AMRS

Amyris

$15.05 /

-0.66 (-4.20%)

Management holds an…

Management holds an investor update conference call on April 22 at 1 pm. Webcast Link

ShowHide Related Items >><<
AMRS Amyris
$15.05 /

-0.66 (-4.20%)

AMRS Amyris
$15.05 /

-0.66 (-4.20%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$15.05 /

-0.66 (-4.20%)

  • 09
    Apr
AMRS Amyris
$15.05 /

-0.66 (-4.20%)

AMRS Amyris
$15.05 /

-0.66 (-4.20%)

Hot Stocks
AnPac Bio reports 5,439 paid cancer tests in Q1, up 130% » 16:21
04/16/21
04/16
16:21
04/16/21
16:21
ANPC

AnPac Bio

$5.01 /

-0.55 (-9.89%)

AnPac Bio announced that…

AnPac Bio announced that it experienced strong demand for its paid tests based on the cancer differentiation analysis technology, or CDA, technology, or paid CDA-based tests, in Q1, setting a record high Q1 test volume. CDA-based tests, which are multi-cancer tests based on a novel biophysical approach, are the company's flagship product line and reached 5,439 paid cancer tests in Q1, an approximately 130% increase over the same period last year. While AnPac Bio offers multiple test products including various cancer screening tests, immunology tests and annual physical checkups, paid CDA-based tests had the highest test volume among all these tests in Q1. While the first three months of the year is traditionally a downtime due to seasonality and the Chinese New Year, the company still experienced strong demand for its commercial CDA-based tests in Q1. This increase in paid CDA-based test volume was also due to the company being negatively impacted by COVID-19 in Q1 of 2020.

ShowHide Related Items >><<
ANPC AnPac Bio
$5.01 /

-0.55 (-9.89%)

ANPC AnPac Bio
$5.01 /

-0.55 (-9.89%)

Options
Closing CBOE SPX and VIX Index summary for April 16th » 16:20
04/16/21
04/16
16:20
04/16/21
16:20
VIX

Volatility Index S&P 500 Options

/

+

The CBOE Volatility Index…

The CBOE Volatility Index (VIX), the SPX option derived measure of implied volatility, fell 0.32 today to close at 16.25, while the underlying SPX index gained 15.05 to close at $4185.47, a 0.36% increase. 775,668 VIX option contracts traded, 1.5729x the typical daily volume for the product. Calls made up 44.3% of the volume.

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
/

+

General news
Treasury Market Summary » 16:20
04/16/21
04/16
16:20
04/16/21
16:20
$ECON

Economic Data

/

+

Treasury Market Summary:…

Treasury Market Summary: the markets remained fairly buoyant into the weekend with Wall Street extending gains while Treasuries consolidated after Thursday's rally. Earnings beats and another batch of solid data provided extra support to stocks with the Dow rising to 34,000, and again outperforming with strength in financials and consumer discretionary. Though little changed overall, longer dated Treasuries outperformed as the 10-year and 30-year maturities stabilized around the 1.575% and 2.260%, respectively. Housing starts beat expectations with a hefty 19.4% surge to 1.739 M, while the rise in consumer confidence to 86.5 was a little below forecast. Fedspeak from Waller underscored the commitment to the accommodative stance. View the summary.

ShowHide Related Items >><<

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.